Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.
Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A.
Arthroscopy. 2020 Aug;36(8):2334-2341. doi: 10.1016/j.arthro.2020.04.044. Epub 2020 May 8.
To synthesize the clinical outcome data of preoperative and postoperative corticosteroid injections (CIs) and their effect on rotator cuff repairs (RCRs).
A systematic review was performed to identify studies that reported the results or clinical outcomes of RCRs in patients receiving either preoperative or postoperative CIs. The searches were performed using MEDLINE, Google Scholar, and Embase, and studies were chosen following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines.
A total of 11 studies were included with data for 176,352 shoulders: 6 studies involving 175,256 shoulders with data regarding preoperative CIs, 4 studies involving 1,096 shoulders with data regarding postoperative CIs, and 1 study with 212 shoulders containing preoperative and postoperative data. Preoperative CIs were found in 3 studies to increase the risk of revision surgery when administered within 6 months (odds ratio [OR], 1.38-1.82) and up to 1 year (OR, 1.12-1.52) prior to RCR, with revision rates in 2 studies being highest when patients received 2 or more injections (OR, 2.12-3.26) in the prior year. Postoperative CIs reduced pain and improved functional outcomes in 5 studies without increasing the retear rates (5.7%-19% for CI and 14%-18.4% for control) in most studies.
CIs provide benefit by relieving pain and improving functional outcome scores. However, repeated preoperative CIs may increase retear rates and the likelihood of revision surgery. A lower frequency of CI and longer preoperative waiting period after CI should be considered to decrease such risks. Postoperative CIs several weeks after RCR do not appear to increase retear rates.
Level IV, systematic review of Level I through IV studies.
综合术前和术后皮质类固醇注射(CIs)的临床结果及其对肩袖修复(RCRs)的影响。
系统检索 MEDLINE、Google Scholar 和 Embase 数据库,以确定报道接受术前或术后 CI 的 RCR 患者结果或临床结局的研究。研究选择遵循 PRISMA(系统评价和荟萃分析的首选报告项目)指南。
共纳入 11 项研究,共涉及 176352 个肩部:6 项研究涉及 175256 个肩部,有术前 CI 数据;4 项研究涉及 1096 个肩部,有术后 CI 数据;1 项研究涉及 212 个肩部,有术前和术后数据。3 项研究发现,术前 CI 在 RCR 前 6 个月(比值比 [OR],1.38-1.82)和长达 1 年(OR,1.12-1.52)内使用会增加翻修手术的风险,2 项研究发现当患者在前一年接受 2 次或更多次注射时,翻修率最高(OR,2.12-3.26)。5 项研究发现,术后 CI 可减轻疼痛并改善功能结局,但大多数研究并未增加再撕裂率(CI 为 5.7%-19%,对照组为 14%-18.4%)。
CI 通过缓解疼痛和提高功能结局评分提供益处。然而,反复进行术前 CI 可能会增加再撕裂率和翻修手术的可能性。应考虑减少 CI 的频率和在 CI 后更长的术前等待期,以降低这些风险。RCR 后数周进行术后 CI 似乎不会增加再撕裂率。
IV 级,对 I 至 IV 级研究的系统评价。